Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
about
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes.Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
P2860
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Antimodified protein antibody ...... modifying antirheumatic drugs.
@en
Antimodified protein antibody ...... modifying antirheumatic drugs.
@nl
type
label
Antimodified protein antibody ...... modifying antirheumatic drugs.
@en
Antimodified protein antibody ...... modifying antirheumatic drugs.
@nl
prefLabel
Antimodified protein antibody ...... modifying antirheumatic drugs.
@en
Antimodified protein antibody ...... modifying antirheumatic drugs.
@nl
P2093
P2860
P1476
Antimodified protein antibody ...... modifying antirheumatic drugs.
@en
P2093
Arnd Kleyer
Axel J Hueber
Bernhard Manger
Camille P Figueiredo
Florian Schuch
Hanns-Martin Lorenz
Holger Bang
Hubert Nuesslein
Jayme Fogagnolo Cobra
Joerg Henes
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-209297
P407
P577
2016-06-20T00:00:00Z